Abstract
Rifampicin (RIF) is one of the most valued drugs in the treatment of tuberculosis. TB treatment relies on a combination therapy and for multidrug-resistant strains may include β-lactams.
Funding Information
  • HHS | National Institutes of Health (R35GM122461)
  • HHS | National Institutes of Health (U19AI162584)
  • HHS | National Institutes of Health (R25140472)

This publication has 73 references indexed in Scilit: